The effects of testosterone on osteoporosis in men

Clinical Endocrinology

Volumn 50, Issue 4, 1999, Pages 411-414

  Francis, R M ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; ESTRADIOL; ETIDRONIC ACID; SEX HORMONE; TESTOSTERONE; TESTOSTERONE ESTER;

ACNE; ANDROGEN THERAPY; AROMATIZATION; AZOOSPERMIA; BONE DENSITY; CLINICAL TRIAL; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; OSTEOPOROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE DISEASE; REVIEW; SIDE EFFECT; WEIGHT GAIN;

BONE DENSITY; FRACTURES, BONE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; OSTEOPOROSIS; RISK FACTORS; TESTOSTERONE;

EID: 0032909560     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1999.00730.x     Document Type: Review

References (43)

1. Anderson, F.H., Francis, R.M. & Faulkner, K. (1996a) Androgen supplementation in eugonadal men with osteoporosis - effects of six months' treatment on bone mineral density and cardiovascular risk factors. Bone, 18, 171-177.
2. Anderson, F.H., Francis, R.M., Hindmarsh, P., Fall, C. & Cooper, C. (1996b) Serum oestradiol in osteoporotic and normal men is related to bone mineral density. In: Osteoporosis '96, (eds S.E. Papapoulos, P. Lips, H.A.P. Pols, C.C. Johnston & P.D. Delmas), pp. 377-381. Elsevier, Amsterdam.
3. Anderson, F.H., Francis, R.M., Peaston, R.T. & Wastell, H.J. (1997) Androgen supplementation in eugonadal men with osteoporosis-effects of six months' treatment on markers of bone formation and resorption. Journal of Bone and Mineral Research, 12, 472-478.
4. Anderson, F.H., Francis, R.M., Selby, P.L. & Cooper, C. (1998) Sex hormones and osteoporosis in men. Calcified Tissue International, 62, 185-188.
5. Baillie, S.P., Davison, C.E., Johnson, F.J. & Francis, R.M. (1992) Pathogenesis of vertebral crush fractures in men. Age and Ageing, 21, 139-141.
6. Behre, H.M., Kliesch, S., Leifke, E., Link, T.M. & Nieschlag, E. (1997) Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. Journal of Clinical Endocrinology and Metabolism, 82, 2386-2390.
7. Bonjour, J.P., Thientz, G., Buchs, B., Slosman, D. & Rizzoli, R. (1991) Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. Journal of Clinical Endocrinology and Metabolism, 73, 555-563.
8. Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., Korach, K.S. & Simpson, E.R. (1997) Effect of testosterone and estradiol in a man with aromatase deficiency. New England Journal of Medicine, 337, 91-95.
9. Christian, J.C., Yu, P.L., Slemenda, C.W. & Johnston, C.C. (1989) Heritability of bone mass: a longitudinal study in ageing male twins. American Journal of Human Genetics, 44, 429-433.
10. Colvard, D.S., Eriksen, E.F., Keeting, P.E., Wilson, E.M., Lubahn, D.B., French, F.S., Riggs, B.L. & Spelsberg, T.C. (1989) Identification of androgen receptors in normal human osteoblast-like cells. Proceedings of the National Academy of Sciences, 86, 854-857.
11. Cooper, C. (1996) Epidemiology and definition of osteoporosis. In: Osteoporosis. New Perspectives on Causes, Prevention and Treatment (ed. J.E. Compston), pp. 1-10. Royal College of Physicians of London, London.
12. Delmas, P. & Meunier, P.J. (1981) L'osteoporose au cours du syndrome de Klinefelter. Nouvelle Presse Medicale, 10, 687-690.
13. Devogelaer, J.P., De Cooman, S. & Nagant de Deuxchaisnes, C. (1992) Low bone mass in hypogonadal males. Effect of testosterone substitution therapy, a densitometric study. Maturitas, 15, 17-23.
14. Dolan, P. & Torgerson, D.J. (1998) The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporosis International, 8, 611-617.
15. Finkelstein, J.S., Klibanski, A., Neer, R.M., Doppelt, S.H., Rosenthal, D.I., Segre, G.V. & Crowley, W.F. (1989) Increases in bone density during treatment of men with idiopathic hypogonadotrophic hypogonadism. Journal of Clinical Endocrinology and Metabolism, 69, 776-783.
16. Finkelstein, J.S., Neer, R.M., Biller, B.M.K., Crawford, J.D. & Klibanski, A. (1992) Osteopenia in men with a history of delayed puberty. New England Journal of Medicine, 326, 600-604.
17. Foresta, C., Busnardo, B., Ruzza, G., Zanatta, G. & Mioni, R. (1983) Lower calcitonin levels in young hypogonadic men with osteoporosis. Hormone and Metabolic Research, 15, 206-207.
18. Francis, R.M. (1998) Cyclical etidronate in the management of osteoporosis in men. Reviews in Contemporary Pharmacotherapy, 9, 261-266.
19. Francis, R.M., Johnson, F.J. & Rawlings, D. (1992) The determinants of bone mass in normal elderly men. In: Current Research in Osteoporosis and Bone Mineral Measurement II: 1992 (ed. E.F.J. Ring), pp. 54-55. British Institute of Radiology, London.
20. Francis, R.M., Peacock, M., Aaron, J.E., Selby, P.L., Taylor, G.A., Thompson, J., Marshall, D.H. & Horsman, A. (1986) Osteoporosis in hypogonadal men: Role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption and low bone formation. Bone, 7, 261-268.
21. Francis, R.M., Peacock, M., Marshall, D.H., Horsman, A. & Aaron, J.E. (1989) Spinal osteoporosis in men. Bone and Mineral, 5, 347-357.
22. Holmang, S., Marin, P., Lindstedt, G. & Hedelìn, H. (1993) Effect of long-term oral testosterone undecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonadal middle-aged men. Prostate, 23, 99-106.
23. Jackson, J.A. & Kleerekoper, M. (1990) Osteoporosis in men: diagnosis, pathophysiology and prevention. Medicine, 69, 137-152.
24. Jackson, J.A., Kleerekoper, M., Parfitt, A.M., Rao, D.S., Villaneuva, A.R. & Frame, B. (1987) Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. Journal of Clinical Endocrinology and Metabolism, 65, 53-58.
25. Jackson, J.A. & Spiekerman, A.M. (1989) Testosterone deficiency is common in men with hip fracture after simple falls. Clinical Research, 37, 131-136.
26. Jackson, J.A., Waxman, J. & Spiekerman, A.M. (1989) Prostatic complications of testosterone replacement therapy. Archives of Internal Medicine, 149, 2365-2366.
27. Kelly, P.J., Pocock, N.A., Sambrook, P.N. & Eisman, J.A. (1990) Dietary calcium, sex hormones, and bone mineral density in men. British Medical Journal, 300, 1361-1364.
28. MacAdams, M.R., White, R.H. & Chipps, B.E. (1986) Reduction of serum testosterone levels during chronic glucocorticoid therapy. Annals of Internal Medicine, 104, 648-651.
29. Matsumoto, A.M. (1990) Effects of chronic testosterone administration in normal men:, safety and efficacy of high dosage testosterone and parallel dose-dependent supression of luteinizing hormone, follicle stimulating hormone and sperm production. Journal of Clinical Endocrinology and Metabolism, 70, 282-286.
30. Meier, D.E., Orwoll, E.S., Keena, E.J. & Fagerstrom, R.M. (1987) Marked decline in trabecular bone mineral in healthy men with age: lack of association with sex steroid levels. Journal of the American Geriatrics Society, 35, 189-197.
31. Murphy, S., Khaw, K.-T., Cassidy, A. & Compston, J.E. (1993) Sex hormones and bone mineral density in elderly men. Bone and Mineral, 20, 133-140.
32. Reid, I.R., France, J.T., Pybus, J. & Ibbertson, H.K. (1985) Plasma testosterone concentrations in asthmatic men treated with glucocorticoids. British Medical Journal, 291, 574.
33. Reid, I.R., Wattic, D.J., Evans, M.C. & Stapleton, J.P. (1996) Testosterone therapy in glucocorticoid-treated men. Archives of Internal Medicine., 156, 1173-1177.
34. Scane, A.C. & Francis, R.M. (1993) Risk factors for osteoporosis in men. Clinical Endocrinology, 38, 15-16.
35. Scane, A.C., Francis, R.M., Johnson, F.J. & Davison, C.E. (1992) The effects of testosterone treatment in eugonadal men with osteoporosis. In: Current Research in Osteoporosis and Bone Mineral Measurement II: 1992 (ed. E.F.J. Ring), p. 54. British Institute of Radiology, London.
36. Seeman, E., Melton, L.J. III, O'Fallon, W.M. & Riggs, B.L. (1983) Risk factors for spinal osteoporosis in men. American Journal of Medicine, 75, 977-983.
37. Slemenda, C., Longcope, C., Zhou, L., Hui, S.L., Peacock, M. & Johnston, C.C. (1997) Sex steroids and bone mass in older men. Positive associations with serum estrogen, and negative associations with androgens. Journal of Clinical Investigation, 100, 1755-1759.
38. Smith, R. (1990) Corticosteroids and osteoporosis. Thorax, 45, 573-578.
39. Smith, E.P., Boyd, J., Frank, G.R., Takahashi, H., Cohen, R.M., Specker, B., Williams, T.C., Lubahn, D.B. & Korach, K.S. (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. New England Journal of Medicine, 331, 1056-1061.
40. Stanley, H.L., Schmitt, B.P., Poses, R.M. & Deiss, W.P. (1991) Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men? Journal of the American Geriatrics Society., 39, 766-771.
41. Śtepan, J.J., Lachman, M., Zverina, J., Pacovsky, V. & Baylink, D.J. (1989) Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodelling. Journal of Clinical Endocrinology and Metabolism, 69, 523-527.
42. Winks, C.S. & Felts, W.J.L. (1980) Effects of castration on the bone structure of male rats: a model of osteoporosis. Calcified Tissue International, 32, 77-82.
43. World Health Organization. (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organization, Geneva.